ENTITY
Peptidream Inc

Peptidream Inc (4587 JP)

42
Analysis
Health Care • Japan
PeptiDream Inc. is a biopharmaceutical company that researches and develops peptide therapeutics to improve the life of patients.
more
Exchange Announcement • 07 Oct 2026 14:30

Peptidream Announces Achievement Of Development Milestone In Collaboration With Msd

Exchange Announcement • 12 Aug 2026 14:30

Consolidated Financial Results For The Six Months Ended June 30, 2026 [Ifrs]

Exchange Announcement • 12 Aug 2026 07:30

Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream

Exchange Announcement • 13 May 2026 14:30

Consolidated Financial Results For The Three Months Ended March 31, 2026 [Ifrs]

Exchange Announcement • 20 Apr 2026 14:30

Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner

x